StockTipsArenaBeta

BUY Zydus Lifesciences Limited — IDBI Capital

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))20 Jul 2026via IDBI Capital Research Calls Telegram

Entry₹1,160Stated
Target₹1,204
Total upside +3.79% (call closed)
Stop loss₹1,138-1.90% risk
Exit₹1,13821 Jul 2026, 10:45 am
Stop-loss hit-1.90%
Follow IDBI Capital for new calls(25% target hit, 375 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Jul 2026
0 supporting1 neutral1 opposing
Supports the BUY call (0)

Nothing found in this tip’s window yet.

Neutral / worth noting (1)

Corporate Actions This Week: Angel One, Bharti Airtel, Hero MotoCorp, Zydus Lifesciences And Pidilite Industries | Full List

NewsNdtv-Profit·19 Jul · yesterday

(opens in new tab)
Weighs against the BUY call (1)

The exchange sought clarification from Zydus Lifesciences Ltd regarding a media report about a Delhi High Court order temporarily restricting the supply of its cancer drug Ikra in a patent dispute.

BSE · Company Update·14 Jul · 6d ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from IDBI Capital

Every call and its outcome